Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

A multi-gene panel study in hereditary breast and ovarian cancer in Colombia

(2017) A. M. Cock-Rada et al.   Familial Cancer

The spectrum of BRCA mutations and characteristics of BRCA-associated breast cancers in China: Screening of 2,991 patients and 1,043 controls by next-generation sequencing

(2017) Guan-Tian Lang et al.   INTERNATIONAL JOURNAL OF CANCER

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

(2017) Karoline B. Kuchenbaecker et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

PARP inhibitors: Synthetic lethality in the clinic

(2017) Christopher J. Lord et al.   SCIENCE

Identification of novelBRCAfounder mutations in Middle Eastern breast cancer patients using capture and Sanger sequencing analysis

(2016) Rong Bu et al.   INTERNATIONAL JOURNAL OF CANCER

Population Frequency of Germline BRCA1/2 Mutations

(2016) Kara N. Maxwell et al.   JOURNAL OF CLINICAL ONCOLOGY

Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care

(2016) Ella R. Thompson et al.   JOURNAL OF CLINICAL ONCOLOGY

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer

(2016) Colin C. Pritchard et al.   NEW ENGLAND JOURNAL OF MEDICINE

Founder and Recurrent Mutations in BRCA1 and BRCA2 Genes in Latin American Countries: State of the Art and Literature Review

(2016) Carlos Andrés Ossa et al.   ONCOLOGIST

Prevalence of Hispanic BRCA1 and BRCA2 mutations among hereditary breast and ovarian cancer patients from Brazil reveals differences among Latin American populations

(2016) Bárbara Alemar et al.   Cancer Genetics

Spectrum of BRCA1/2 variants in 940 patients from Argentina including novel, deleterious and recurrent germline mutations: impact on healthcare and clinical practice

(2016) Angela Rosaria Solano et al.   Oncotarget

The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer

(2015) C. Villarreal-Garza et al.   BREAST CANCER RESEARCH AND TREATMENT

Association of Type and Location ofBRCA1andBRCA2Mutations With Risk of Breast and Ovarian Cancer

(2015) Timothy R. Rebbeck et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Significant clinical impact of recurrentBRCA1andBRCA2mutations in Mexico

(2014) Cynthia Villarreal-Garza et al.   CANCER

Prevalence ofBRCA1andBRCA2mutations in unselected breast cancer patients from Peru

(2014) J. Abugattas et al.   CLINICAL GENETICS

Haplotype analysis of the 185delAG BRCA1 mutation in ethnically diverse populations

(2012) Yael Laitman et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

Prevalence and Type of BRCA Mutations in Hispanics Undergoing Genetic Cancer Risk Assessment in the Southwestern United States: A Report From the Clinical Cancer Genetics Community Research Network

(2012) Jeffrey N. Weitzel et al.   JOURNAL OF CLINICAL ONCOLOGY

BRCA1 and BRCA2 mutations among ovarian cancer patients from Colombia

(2011) Alexandra Ortiz Rodríguez et al.   GYNECOLOGIC ONCOLOGY

The impact of Converso Jews on the genomes of modern Latin Americans

(2011) C. Velez et al.   HUMAN GENETICS

Germline mutations in BRCA1 and BRCA2 genes in ethnically diverse high risk families in Israel

(2010) Yael Laitman et al.   BREAST CANCER RESEARCH AND TREATMENT

Spectrum of BRCA1/2 point mutations and genomic rearrangements in high-risk breast/ovarian cancer Chilean families

(2010) Patricio Gonzalez-Hormazabal et al.   BREAST CANCER RESEARCH AND TREATMENT

Identification of novel large genomic rearrangements at the BRCA1 locus in Malaysian women with breast cancer

(2010) Noor Akmal Sharifah et al.   Cancer Epidemiology

On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations

(2010) Nancy Hamel et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality

(2010) Susan M. Domchek   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Comprehensive mutational analysis ofBRCA1/BRCA2for Korean breast cancer patients: evidence of a founder mutation

(2009) M-W Seong et al.   CLINICAL GENETICS

BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications

(2009) Allison W Kurian   CURRENT OPINION IN OBSTETRICS & GYNECOLOGY

Haplotype of the C61G BRCA1 Mutation in Polish and Jewish Individuals

(2009) Bella Kaufman et al.   Genetic Testing and Molecular Biomarkers

A common Greenlandic Inuit BRCA1 RING domain founder mutation

(2008) Thomas v. O. Hansen et al.   BREAST CANCER RESEARCH AND TREATMENT

The Role of the BRCA2 Gene in Susceptibility to Prostate Cancer Revisited

(2008) E. A. Ostrander et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Evidence for an ancient BRCA1 mutation in breast cancer patients of yoruban ancestry

(2008) Bifeng Zhang et al.   Familial Cancer

Does the nonsense-mediated mRNA decay mechanism prevent the synthesis of truncated BRCA1, CHK2, and p53 proteins?

(2007) Olga Anczuków et al.   HUMAN MUTATION